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Abstract
Objective. The relationship between fatigue and
pain has been investigated previously, but little is
known about the prevalence of substantial fatigue in
patients sick-listed for chronic low back pain (CLBP)
and about how fatigue is associated with depres-
sion, pain, and long-term disability. The aims of the
study were to examine the prevalence of substantial
fatigue; associations between fatigue, depression,
and pain; and whether fatigue predicted long-term
disability.
Methods. Five hundred sixty-nine patients partici-
pating in a randomized controlled trial and sick-
listed 2–10 months for LBP were included in the
study. Cross-sectional analyses were conducted to
investigate the prevalence and independent asso-
ciations between fatigue, depression, pain, and dis-
ability, while longitudinal analyses were done to
investigate the association between fatigue and
long-term disability.
Results. The prevalence of substantial fatigue was
69.7%. Women reported signiﬁcantly more fatigue
than men (t =− 3.6, df = 551; P < .001). Those with
substantial fatigue had higher pain intensity
(t =− 3.3, df = 534; P = 0.01), more depressive symp-
toms (t =− 10.9, df = 454; P < 0.001), and more dis-
ability (t =− 7.6, df = 539; P < 0.001) than those
without substantial fatigue. Musculoskeletal pain
and depression were independently associated with
substantial fatigue. In the longitudinal analyses,
fatigue predicted long-term disability at 3, 6, and 12
months’ follow-up. After pain and depression were
controlled for, fatigue remained a signiﬁcant predic-
tor of disability at 6 months’ follow-up.
Conclusions. The vast majority of the sick-listed
CLBP patients reported substantial fatigue. Those
with substantial fatigue had more pain and depres-
sive symptoms and a signiﬁcant risk of reporting
more disability at 3, 6, and 12 months. Substantial
fatigue is disabling in itself but also involves a risk
of developing chronic fatigue syndrome and long-
term disability.
Key Words. Low Back Pain; Fatigue; Depression;
Disability
Introduction
Chronic low back pain (CLBP) represents a major public
health problem in Western societies. It is the leading cause
of long-term sick leave in Norway and is often associated
with substantial disability [1,2] and a high degree of
comorbidity. The comorbidity involves both mental disor-
ders [3] and other health complaints [4], including tired-
ness and fatigue [5].
Fatigue is a subjective health complaint that entails emo-
tional, cognitive, and behavioral components [6]. The
current study will be covering the mental and physical
aspects of fatigue [7], as described and applied in previ-
ous studies [8,9]. More speciﬁcally, these involve cognitive
difﬁculties, tiredness and sleepiness, reduced strength
and endurance, and loss of interest and motivation [10].
Fatigue is a common complaint in the general population
[8,9]. It often accompanies physical diseases [11–14] and
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severe symptom in chronic fatigue syndrome (CFS) [16].
Patients with various pain syndromes also report fatigue.
A higher occurrence of fatigue was found in patients with
complex regional pain syndrome compared with a control
group [17], and patients with ﬁbromyalgia were more
fatigued than the general population [18]. Two previous
studies have shown that CLBP patients are more fatigued
than healthy controls [19,20], but less is known about the
prevalence of substantial fatigue in CLBP compared with
the general population and about how fatigue may inﬂu-
ence the prognosis of CLBP.
Depression is a factor known to inﬂuence the prognosis of
CLBP [21]. In fact, depression is both a risk factor for [22]
and a consequence of chronic pain [23], and patients with
concurrent pain and depression have more intense and
continuous pain, more functional limitations, and slower
recovery [23,24]. The presence of depressive symptoms is
also strongly associated with chronic fatigue [25], and
depression could thus be a contributing etiological factor
of the reported fatigue in chronic pain patients.
A related problem, clinical insomnia, is also highly preva-
lent among patients with chronic back pain [26]. A study
from a large, heterogeneous sample of patients who were
seeking care for their LBP revealed that 59% of the
patients reported poor sleep [27]. Sleep is thus increas-
ingly recognized as an important parameter in determining
quality of life in chronic pain patients and could be an
underlying factor of the fatigue in CLBP.
The pain itself could also be a contributing cause of the
fatigue, with fatigue and pain both contributing to a
synergistic reduction of functional capacity in CLBP.
Co-occurrence of fatigue and CLBP may thus contribute
to a greater loss of function [3] as well as an increased risk
for sick leave [28].
The primary aim of this study was to investigate the preva-
lence of substantial fatigue, deﬁned as a score of ≥4o n
the Chalder Fatigue Scale [7], in sick-listed CLBP patients.
Secondary aims involved assessing associations between
fatigue, depression, pain, subjective health complaints,
and disability and exploring how fatigue inﬂuenced the
prognosis at 3, 6, and 12 months’ follow-up. We hypoth-
esized that substantial fatigue would be associated with
more widespread and intense musculoskeletal health
complaints and depression and that pain, depression, and
fatigue would predict disability after 3, 6, and 12 months.
Methods
A total of 569 patients who were sick-listed with nonspe-
ciﬁc LBP for between 2 and 10 months were included in
the study as part of a multicenter randomized controlled
trial. Details are described in the trial protocol [29]. The
work was conducted at Uni Health, Uni Research AS,
Bergen, Norway. Patients on sick leave for nonspeciﬁc
LBP (International Classiﬁcation of Primary Care [WHO,
2003]: L03, L04, L84, and L86) received information from
the Norwegian Labour and Welfare Administration about
the possibility of participating in a multicenter randomized
controlled trial of different treatments for CLBP. Those who
responded to the invitation (N = 2,200) were screened by
telephone and excluded if they did not fulﬁll the following
inclusion criteria: currently being on sick leave due to LBP
and having been so for between 2 and 10 months, being
between 18 and 60 years of age, and being ﬂuent in the
Norwegian language. A total of 1,563 patients were
excluded at this stage. The remaining 637 patients were
referred to the participating clinics for inclusion, and 63
were excluded due to the following exclusion criteria:
pregnancy (N = 1), known osteoporotic fracture or being
on antiosteoporotic medication (N = 5), ongoing treatment
for cancer (N = 2), recent back trauma (N = 11), serious
psychiatric disorder (mainly due to ongoing psychosis,
high suicide risk, and/or serious depression; N = 8),
cardiovascular disease (N = 1), and nonﬂuency in the Nor-
wegian language (N = 6). A standardized psychiatric inter-
view was used to screen for psychiatric disorders. One
patient withdrew his consent and demanded that all data
be deleted, and another 4 patients were excluded after
randomization, leaving 569 patients included in the analy-
ses.
The patients answered a number of different question-
naires at baseline and at 3, 6, and 12 months’ follow-up
concerning pain, fatigue, anxiety, depression, subjective
health complaints, and functional limitations. In addition,
demographic variables such as gender, age, civil status,
and education were recorded. The response rates for the
follow-up assessments were 55% at 3 months, 49% at 6
months, and 68% at 12 months.
Questionnaires
Pain
Mean back pain severity during the last 14 days was
registered using a visual analog rating scale (VAS scale)
divided into 11 equal parts with scores from 0 to 10, with
0 labeled “no pain” and ten “worst possible pain.” The
patients were also asked to mark on a body chart where
they had experienced pain during the last week and to
rate the intensity of neck pain and leg pain on VAS scales.
Depression
The Hospital Anxiety and Depression Scale (HADS) has
been shown to be a useful device for assessing presence
of clinically signiﬁcant degrees of anxiety and depression
[30]. The HADS is a 14-item scale and is scored on a
four-point Likert scale. It was originally developed for use
in patients with physical illness, with excluded items con-
cerning somatic symptoms in anxiety and depression. The
scale hence avoids overlap with somatic symptoms of
physical illness. Fourteen items measuring anxiety and
depression over the last week (seven each) provide a total
score of between 0 and 21 for each subscale. Higher
scores on these subscales represent increased probability
of an anxiety or depressive disorder being present. We
1164 © 2014 The Authors. Pain Medicine published by Wiley Periodicals, Inc. on behalf of American Academy of Pain Medicine.
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with scores of 8 and above being used as an indication of
possible depression [31].
Fatigue
The Chalder Fatigue Scale [7] is a self-rating scale devel-
oped to measure the severity of fatigue. The intended
purpose of the scale is to detect fatigue cases and to
assess symptom severity in both hospital and community
populations. It is an 11-item scale and has been found to
be both reliable and valid [7,32]. The patients are asked to
rate how tired they have or have not been over the last
month, with the following response alternatives: “better
than usual,” “no more than usual,” “worse than usual,” and
“much worse than usual”; the higher the score, the more
fatigued the patient. If participants had been feeling tired
for a long time, they were asked to compare their tired-
ness with how they felt when last well. The bimodal
scoring system allows for fatigue cases to be identiﬁed. In
contrast to the Likert scoring system (0, 1, 2, 3), where the
maximum score possible is 33, the bimodal scoring
system (0, 0, 1, 1) has a maximum score of 11, where the
response options “less than usual” and “no more than
usual” are given scores of 0 and “worse than usual” and
“much worse than usual” are given scores of 1. “Substan-
tial fatigue” was deﬁned by total dichotomized scores of 4
or higher. This cutoff was originally suggested by a previ-
ous validation study of the Chalder Fatigue Scale [7] and
had since been applied in two population studies, thus
providing norms that could be used for comparison [8,9].
Subjective Health Complaints
The Subjective Health Complaints (SHC) inventory [33] is
a 29-item questionnaire designed to measure preva-
lence, degree, and duration of common subjective health
complaints. The patients are asked if and, if yes, to what
extent they have been affected by any of 29 complaints
during the last month, using the following options: 0 (not
at all), 1 (a little), 2 (some), or 3 (seriously). The 29 items
may be categorized into ﬁve subscales: musculoskeletal
complaints (headache, neck pain, shoulder pain, pain
in upper back, low back pain, pain in arms, leg pain,
migraine), pseudoneurological conditions (extra heart-
beats, hot ﬂashes, sleep problems, tiredness, dizziness,
anxiety, sadness/depression), gastrointestinal complaints
(heartburn, stomach discomfort, ulcer/nonulcer dyspep-
sia, stomach pain, gas discomfort, diarrhea, constipa-
tion), allergy (asthma, breathing difﬁculties, eczema,
allergy, chest pain), and ﬂu (cold/ﬂu, coughing). In the
current study, severity of complaints was also computed
for each subscale.
Disability
The Oswestry Disability Index [34] was used to assess
functional limitation or disability at baseline and at 3-, 6-,
and 12-month follow-up. It consists of 10 items concern-
ing the effect of back pain on different activities of daily life
(personal care, lifting, walking, sitting, standing, sleeping,
sexual life, social life, and travelling). The patients are
asked about their current functional status. Each item is
scored from 0 to 5, with higher values representing more
disability. In the current study we used a median split and
deﬁned those in the upper half (with a score of >28) as
substantially disabled.
Statistical Analyses
All analyses were performed with SPSS version 18.
Descriptive statistics, involving frequency tables, cross-
tabs, and independent-sample t-tests, was used to
assess the prevalence of substantial fatigue and to
compare differences between groups, i.e., those with and
without substantial fatigue. Multiple logistic regression
was used to investigate associations between the vari-
ables and possible confounders, both cross-sectionally
and longitudinally. Additional correlation analyses were
conducted between the independent variables to test for
potential multicollinearity.
Ethical Considerations
The Regional Ethical Committee and the Norwegian
Social Science Data Services National Register of Data
approved the study. All principles in the Helsinki declara-
tion were followed. Informed consent was signed by each
participant with emphasis on the right to withdraw from
the study at any time without any explanation.
Results
The study population was 50.3% women, and the mean
age was 44 years. Patients reported an average of 11
years’ duration for their back pain (Table 1), with 99.6%
reporting pain lasting for more than 3 months. Three
hundred seventy-eight (69.7%) reported substantial
fatigue, with a score of 4 or more on the Chalder Fatigue
Scale. Women reported signiﬁcantly higher scores on
fatigue compared with men (t =− 3.6, df = 551; P < .001).
One hundred one patients (18%) were possibly
depressed, with a score of 8 or more on the HADS
depression subscale. No gender differences were seen
for depression (χ2 = 0.06, P = 0.44).
Patients with substantial fatigue had higher pain intensity
(t =− 3.3, df = 534; P = 0.01), more depressive symp-
toms (t =− 10.9, df = 454; P < 0.001), and more disability
(t =− 7.6, df = 539; P < 0.001) compared with those
without substantial fatigue. Seventeen percent of the
CLBP patients were both substantially fatigued (≥4o n
fatigue scale) and scored above the cutoff for depressive
symptoms (≥8 on HADS).
In the univariate models, female gender, back pain, leg
pain, anxiety, depression, and the SHC subscales for gas-
trointestinal problems, ﬂu, and musculoskeletal pain were
signiﬁcantly associated with substantial fatigue. Higher
scores were associated with substantial fatigue (Table 2).
In the multivariate model, gender, age, civil status, and
length of education were included as control variables.
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inventory was highly correlated with depression (r = 0.51,
P < .001) and was thus excluded from the ﬁnal model in
order to avoid multicollinearity. In the ﬁnal model, higher
scores on the depression scale, musculoskeletal pain, and
leg pain were signiﬁcantly and independently associated
with substantial fatigue (see Table 2).
The same model was run with disability as outcome in
order to test another hypothesis, namely that stronger
pain, fatigue, and depressive symptoms were asso-
ciated with substantial disability (score >28 on the
Oswestry Disability Index). Higher scores for fatigue,
depressive symptoms, and musculoskeletal pain
(including back and leg pain) were signiﬁcantly and
independently associated with substantial disability (see
Table 3).
Finally, the longitudinal analyses showed that fatigue pre-
dicted disability at 3, 6, and 12 months’ follow-up when
demographic variables and baseline level of disability were
controlled for. When pain and depression were added as
potential covariates, fatigue remained a signiﬁcant predic-
tor of disability at 6 months (Table 4).
Discussion
A total of 70% of the 569 patients with CLBP reported
substantial fatigue (dichotomized scores 4 or higher) in the
current study. More women than men were fatigued.
Those who were substantially fatigued had higher pain
intensity, more depressive symptoms, and more functional
disability than those without substantial fatigue. In the
multiple regression models, musculoskeletal pain and
depression were independently associated with substan-
tial fatigue, while pain intensity, depression, and fatigue
were independently associated with substantial disability.
This implies that the fatigue is fully explained neither by
depression nor by pain intensity. The longitudinal analyses
further conﬁrmed that the severity of fatigue was a signiﬁ-
cant predictor of disability at 3, 6 and 12 months’ follow-
up. This association remained signiﬁcant at 6 months’
follow-up when pain intensity and depression were
controlled for.
The prevalence of substantial fatigue reported here is far
higher than in the general Norwegian population, where
22% reported substantial fatigue [9]. It is also higher than
what was reported in the general British population, where
37% reported substantial fatigue [8]. Our ﬁnding of more
fatigue in women than in men is, however, in accordance
with previous ﬁndings [8]. Our results are further in agree-
ment with two previous studies on CLBP and fatigue,
where the CLBP patients reported signiﬁcantly more
fatigue than the healthy controls [19,20]. Compared with
other patient populations, more CLBP patients than
patients with rheumatoid arthritis (42%) and osteoarthritis
(41%) report substantial fatigue, but the number who do
so is comparable with that of patients with ﬁbromyalgia
(76%) [35]. The prevalence of clinically relevant fatigue in
patients with different cancer diagnoses has been found
to vary from 19% (testicular cancer) to 38% (breast
cancer) [13].
Pain is one common aspect of rheumatoid arthritis, osteo-
arthritis, ﬁbromyalgia, and LBP, and one might hypoth-
esize that pain is a contributing cause of the fatigue. Three
studies of diabetic patients with peripheral neuropathic
pain supported this hypothesis; after treatment with
duloxetine, the patients reported less pain and improve-
ments in perceived fatigue [36–38]. A path analysis of the
results further suggested that fatigue improvement was
mediated by reductions in pain, night pain, and sleep
interference [39]. Thus, although not able to conﬁrm a
causal link between reduced pain and improved fatigue,
ﬁndings indicate that reduced fatigue may be secondary
to improvements in pain [40] and that the relationship may
be etiological [41]. The current study provides some
support for this notion in that the predictive value of fatigue
Table 1 Baseline and clinical characteristics
(N = 569)
Continuous variables Mean SD Median
Age 44.3 years 9.7 44
Duration of back pain 10.8 years 10.5 7.5
Back pain intensity
(0–10)
6.5 1.9 7.0
Neck pain intensity
(0–10)
3.8 2.8 4.0
Leg pain intensity (0–10) 3.9 2.7 4.0
Pain during activity
(0–10)
5.9 2.2 6.0
Pain while resting (0–10) 4.0 2.3 4.0
Subjective health
complaints (number
of complaints)
10.0 4.9 10.0
Categorical variables N %
Gender
Men 283 49.7
Women 286 50.3
Civil status
Married/cohabiting 396 71.7
Single/widow/divorced 156 28.3
Education
Primary school, 1–12 years 386 70.2
University/college 164 29.8
HADS
Depression (score ≥8) 101 18.3
Anxiety (score ≥8) 125 22.6
Subjective health complaints
Musculoskeletal complaints 528 99.2
Pseudoneurological complaints 477 89.7
Gastrointestinal complaints 360 67.5
Allergy 243 45.6
Flu 228 42.9
HADS = Hospital Anxiety and Depression Scale.
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covariates in the longitudinal analyses.
Eighteen percent of the CLBP patients scored high on
depressive symptoms, with a score of 8 or more on the
HADS depression subscale. This was not unexpected
given the close relationship between pain and depression
seen in previous literature [42–45]. A score of 8 or more on
the HADS depression subscale has previously been found
to be a strong predictor of both work disability and mor-
tality [46,47]. We found that depressive symptoms were
strongly correlated with fatigue, and a subgroup of 17%
reported both substantial fatigue and depressive symp-
toms. Comorbid fatigue and depression might reduce the
patients’ functional capacity, and this synergistic effect of
what are usually referred to as “symptom clusters” has
been thoroughly demonstrated [48,49].
Substantial fatigue is also a predictor of chronic fatigue
and CFS [50,51]. Although a lack of CFS screening in the
study makes us unable to rule out already existent CFS,
the reported substantial fatigue could still represent a risk
Table 2 Univariate and multivariate associations between substantial fatigue and other clinical and
demographic variables
Univariate associations Multivariate model
OR (95% CI) P value OR (95% CI) P value
Age 1.00 (0.98–1.02) 0.80 0.98 (0.95–1.00) 0.06
Marital status 0.79 (0.52–1.20) 0.27 0.87 (0.51–1.48) 0.60
Education 1.25 (0.83–1.88) 0.29 1.07 (0.63–1.80) 0.80
Gender 2.02 (1.39–2.94) <0.001 1.62 (1.00–2.63) 0.05
Back pain intensity 1.18 (1.07–1.30) 0.001 0.97 (0.85–1.11) 0.68
Leg pain intensity 1.15 (1.07–1.24) <0.001 1.10 (1.01–1.21) 0.04
Anxiety (HADS anxiety scale) 1.30 (1.21–1.40) <0.001 1.09 (0.98–1.21) 0.10
Depression (HADS depression scale) 1.41 (1.30–1.53) <0.001 1.28 (1.15–1.43) <0.001
Gastrointestinal problems (SHC) 1.16 (1.06–1.26) 0.001 0.96 (0.85–1.08) 0.46
Flu (SHC) 1.31 (1.10–1.56) 0.03 1.21 (1.00–1.48) 0.053
Musculoskeletal pain (SHC) 1.29 (1.21–1.37) <0.001 1.22 (1.13–1.31) <0.001
Outcome variable is substantial fatigue (≥4 on the Chalder Fatigue Scale).
OR = odds ratio; CI = conﬁdence interval; HADS = Hospital Anxiety and Depression Scale; SHC = Subjective Health Complaints
inventory.
Table 3 Univariate and multivariate associations between functional disability and other clinical and
demographic variables
Univariate associations Multivariate model
OR (95% CI) P value OR (95% CI) P value
Age 1.00 (0.98–1.01) 0.68 0.99 (0.97–1.01) 0.39
Marital status 0.74 (0.51–1.07) 0.11 0.78 (0.49–1.24) 0.29
Education 0.72 (0.50–1.05) 0.09 0.84 (0.53–1.33) 0.46
Gender 1.19 (0.85–1.66) 0.32 1.06 (0.69–1.63) 0.80
Fatigue 3.59 (2.38–5.39) <0.001 2.43 (1.43–4.14) 0.001
Back pain intensity 1.52 (1.36–1.70) <0.001 1.38 (1.21–1.58) <0.001
Leg pain intensity 1.23 (1.15–1.32) <0.001 1.13 (1.05–1.23) 0.002
Anxiety 1.11 (1.06–1.17) <0.001 0.95 (0.88–1.03) 0.24
Depression 1.18 (1.11–1.24) <0.001 1.13 (1.03–1.23) 0.007
Gastrointestinal problems (SHC) 1.15 (1.07–1.23) <0.001 1.04 (0.95–1.14) 0.38
Flu (SHC) 1.16 (1.01–1.33) 0.04 1.13 (0.96–1.33) 0.15
Musculoskeletal pain (SHC) 1.16 (1.11–1.22) <0.001 1.06 (1.00–1.13) 0.058
Outcome variable is disability (>28 on the Oswestry Disability Index).
OR = odds ratio; CI = conﬁdence interval; SHC = Subjective Health Complaints inventory.
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stage of CLBP. Fatigue was a strong predictor of
long-term disability, which implies that fatigue and its
consequences may need to be considered when CLBP
treatment programs are planned. Indeed, multimodal
treatment programs for patients with both CLBP and
fatigue have indicated good results [52]. Further, reducing
pain may in itself contribute to less fatigue, particularly
night pain and pain interfering with sleep [39]. Also,
addressing the fatigue directly in rehabilitation programs
may give additional effects, as cognitive–behavioral
therapy and graded exercise therapy have produced sig-
niﬁcant improvements in fatigue for patients with CFS
[53,54].
The study has a few limitations that will now be consid-
ered. First, the participants were not formally screened
for CFS, ﬁbromyalgia, or sleep disorders. These condi-
tions can therefore not be ruled out as underlying causes
of the fatigue, thereby calling into question the represen-
tativeness of the CLBP population. However, the fact
that all study participants were on sick leave due to LBP
implies that they were representative of this population
by deﬁnition. Although an underlying comorbid diagnosis
of, e.g., CFS cannot be ruled out, this was not their
primary reason for being unable to work, and it was not
their primary reason for seeking treatment. A systematic
screening for CFS in this population would, however, be
interesting and should be pursued in future studies.
Second, the use of different fatigue scales might be a
problem when comparing fatigue across studies. Still,
the most important comparison for the current study
were the studies from the general population, which
used both the same scale and cutoff as in the current
study [8,9]. Last, loss to follow-up is also a limitation that
needs to be considered. The longitudinal analyses, espe-
cially at 6 months’ follow-up, suffer from a high rate of
missing data, and these results should thus be inter-
preted with some care.
In conclusion, we found that the vast majority of sick-listed
CLBP patients reported substantial fatigue, and more
so for women than for men. Musculoskeletal pain and
depression were associated with substantial fatigue, while
intense pain, depression, and fatigue were associated
with substantial disability. The patients with substantial
fatigue had higher pain intensity and more disability and
were more depressed than those without, and severity of
fatigue was a signiﬁcant predictor of long-term disability.
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